Course Code: BENG 311P Credits: 15 UCL credits (7.5 ECTS) Term delivered: Term 1 Year of study: 3 Aims and Learning Outcomes: Course Title: Advanced Materials, Devices and Manufacturing Processes for Regenerative Medicine Teaching Team: Dr Ivan Wall Prof Chris Mason Dr Farlan Veraitch Pre-requisites: The aim of the module is to provide students with a working understanding of advanced biomaterials and process discovery devices that are used for regenerative medicines manufacture and the considerations regarding infrastructure requirements for clinical grade manufacture of regenerative medicines. This will provide students with the skills that would be highly desirable by a growing regenerative medicine manufacture industry and the Cell Therapy Catapult. By completing this module, students will: Understand the physical, mechanical and thermal properties of different materials and their application to manufacturing processes for emerging regenerative medicines. Appreciate novel technologies currently employed for regenerative medicine manufacture, with specific emphasis on the utility and application of microfluidic devices to process discovery. Develop an understanding of how new manufacturing processes for stem cells rely upon clinical grade manufacturing. Synopsis: In this module, students will learn about the importance of biomaterials, as part of implanted, tissue-engineered devices and also as physical substrates for the attachment and growth of stem cells during manufacturing processes. Materials are also an important consideration for devices that are created to support process development. Examples of such devices include microfluidic devices, which are gaining substantial ground as process development tools to support regenerative medicine translation. These devices will be examined from a materials and engineering perspective and students will develop an understanding of the utility and power of these tools for stem cell culture. Finally, building on earlier lectures in this module and BENG212P, principles of clinical grade manufacturing will be taught and a trip to a regenerative medicines manufacturing facility will also provide a real world learning experience that helps students familiarize with large scale processes and regulatory requirements. Method of delivery: Assessment: Fundamental information will be delivered in the form of lectures. Then, interactive workshops will be the main forum by which clinical case studies are used to generate and exchange ideas about the defined needs of industrial processes and automation in small groups and as a whole class. The workshops will be used to develop the student’s understanding of the utility of different biomaterial substrates and subsequently the benefits and limitations of different technology platforms for GMP manufacture. A total of 40 hours contact time over the 10 weeks of term 1 are timetabled. Examination (2hr written exam) 60% Coursework (2 written courseworks) 30% Workshop engagement 10% 1